Protection against respiratory syncytial virus infection by DNA immunization

Journal of Experimental Medicine

Volumn 188, Issue 4, 1998, Pages 681-688

  Li, Xiaomao ^a   Sambhara, Suryaprakash ^a   Li, Cindy Xin ^a   Ewasyshyn, Mary ^a   Parrington, Mark ^a   Caterini, Judy ^a   James, Olive ^a   Cates, George ^a   Du, Run Pan ^a   Klein, Michel ^a  

^a Research Centre   (Canada)

Author keywords

DNA vaccine; F protein; Immune modulation; Respiratory syncytial virus; Vector design

Indexed keywords

BETA GLOBIN; DNA VACCINE; FORMALDEHYDE; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MESSENGER RNA; NEUTRALIZING ANTIBODY; PLASMID VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRON; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; GENETIC VECTORS; HN PROTEIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MALE; MICE; MICE, INBRED BALB C; PLASMIDS; RABBITS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TH1 CELLS; TH2 CELLS; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 18344410538     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.4.681     Document Type: Article

References (40)

1. Hall, C.B. 1994. Prospects for a respiratory syncytial virus vaccine. Science. 265:1393-1394.
2. Falsey, A.R., and E.E. Walsh. 1992. Humoral immunity to respiratory syncytial virus infection in the elderly. J. Med. Virol. 36:39-43.
3. Murphy, B.R., S.L. Hall, A.B. Kulkarni, J.E. Crowe, Jr., P.L. Collins, M. Connors, R.A. Karron, and R.M. Chanock. 1994. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus. Res. 32:13-36.
4. Johnson, P.R., Jr., R.A. Olmsted, G.A. Prince, B.R. Murphy, D.W. Alling, E.E. Walsh, and P.L. Collins. 1987. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J. Virol. 61: 3163-3166.
5. Johnson, P.R., and P.L. Collins. 1988. The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. J. Gen. Virol. 69:2623-2628.
6. Isaacs, D., C.R. Bangham, and A.J. McMichael. 1987. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet. 2:769-771.
7. Cherrie, A.H., K. Anderson, G.W. Wertz, and P.J. Openshaw. 1992. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J. Virol. 66:2102-2110.
8. Kapikian, A.Z., R.H. Mitchell, R.M. Chanock, R.A. Shvedoff, and C.E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
9. Kim, H.W., J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Chanock, K. Jensen, and R.H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
10. Openshaw, P.J. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol. 17:187-201.
11. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
12. Connors, M., A.B. Kulkarni, C.Y. Firestone, K.L. Holmes, H.C. Morse III, A.V. Sotnikov, and B.R. Murphy. 1992. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66:7444-7451.
13. Graham, B.S., G.S. Henderson, Y.W. Tang, X. Lu, K.M. Neuzil, and D.C. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
14. Waris, M.E., C. Tsou, D.D. Erdman, S.R. Zaki, and L.J. Anderson. 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:2852-2860.
15. Srikiatkhachorn, A., and T.J. Braciale. 1997. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J. Virol. 71:678-685.
16. Crowe, J.E., Jr., P.T. Bui, G.R. Siber, W.R. Elkins, R.M. Chanock, and B.R. Murphy. 1995. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine. 13:847-835.
17. Ulmer, J.B., J.C. Sadoff, and M.A. Liu. 1996. DNA vaccines. Curr. Opin. Immunol. 8:531-536.
18. Pertmer, T.M., T.R. Roberts, and J.R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70: 6119-6125.
19. Justewicz, D.M., and R.G. Webster. 1996. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology. 224: 10-17.
20. Pizzorno, M.C., P. O'Hare, L. Sha, R.L. LaFemina, and G.S. Hayward. 1988. trans-Activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J. Virol. 62:1167-1179.
21. Du, R.P., G.E. Jackson, P.R. Wyde, W.Y. Yan, Q. Wang, L. Gisonni, S.E. Sanhueza, M.H. Klein, and M.E. Ewasyshyn. 1994. A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3. Biotechnology (NY). 12:813-818.
22. Davis, H.I., M.-L. Michel, M. Mancini, M. Schleel, and R.G. Whalen. 1994. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine. 12:1503-1509.
23. Graham, B.S., M.D. Perkins, P.F. Wright, and D.T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162.
24. Prince, G.A., A.B. Jenson, R.L. Horswood, E. Camargo, and R.M. Chanock. 1978. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am. J. Pathol. 93:771-791.
25. Fernie, B.F., E.C. Ford, and J.L. Gerin. 1981. The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proc. Soc. Exp. Biol. Med. 167:83-86.
26. Qin, S., M. Wise, S.P. Cobbold, L. Leong, Y.-C. Kong, J.R. Parnes, and H. Waldmann. 1990. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20:2737-2745.
27. Wilde, D.B., P. Marrack, J. Kappler, D.P. Dialynas, and F.W. Fitch. 1983. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J. Immunol. 131:2178-2183.
28. Ledbetter, J.A., R.H. Rouse, H.S. Micklem, and L.A. Herzenberg. 1980. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. J. Exp. Med. 152:280-295.
29. Ozato, K., N.M. Mayer, and D.H. Sachs. 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation. 34:113-120.
30. Kappler, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. J. Exp. Med. 153:1198-1214.
31. Murphy, B.R., A. Sotnikov, P.R. Paradiso, S.W. Hildreth, A.B. Jenson, R.B. Baggs, L. Lawrence, J.J. Zubak, R.M. Chanock, J.A. Beeler, et al. 1989. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine. 7:533-540.
32. Doe, B., M. Selby, S. Barnett, J. Baenziger, and C.M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA. 93: 8578-8583.
33. Iwasaki, A., C.A. Torres, P.S. Ohashi, H.L. Robinson, and B.H. Barber. 1997. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:11-14.
34. Connors, M., P.L. Collins, C.Y. Firestone, A.V. Sotnikov, A. Waitze, A.R. Davis, P.P. Hung, R.M. Chanock, and B.R. Murphy. 1992. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia - RSV recombinants or RSV. Vaccine. 10:475-484.
35. Graham, B.S. 1995. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am. J. Respir. Crit. Care Med. 152:563-66.
36. Doherty, P.C. 1994. Vaccines and cytokine-mediated pathology in RSV infection. Trends Microbiol. 2:148-150.
37. Hancock, G.E., D.J. Speelman, P.J. Frenchick, M.M. Mineo-Kuhn, R.B. Baggs, and D.J. Hahn. 1995. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection. Vaccine. 13:391-100.
38. Tang, Y.W., and B.S. Graham. 1997. T cell source of Type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Invest. 99:2183-2191.
39. Raz, E., H. Tighe, Y. Sato, M. Corr, J.A. Dudler, M. Roman, S.L. Swain, H.L. Spiegelberg, and D.A. Carson. 1996. Preferential induction of a Th1 immune response and inhibition of specific IgG antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:5141-5145.
40. Donnelly, J.J., J.B. Ulmer, J.W. Shiver, and M.A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.